The application of phosphoramidate ProTide technology to acyclovir confers anti-HIV inhibition

Recently it has been reported that phosphorylated acyclovir (ACV) inhibits human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in a cell free system. To deliver phosphorylated ACV inside cells we designed ACV monophosphorylated derivatives using ProTide technology. We found that the L-...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Derudas, Marco, Carta, Davide, Brancale, Andrea, Vanpouille, Christophe, Lisco, Andrea, Margolis, Leonid, Balzarini, Jan, McGuigan, Christopher
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2748767/
https://ncbi.nlm.nih.gov/pubmed/19645484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm9007856
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items